Open AccessResponse to trametinib in a nonsmall cell lung cancer patient with osimertinib resistance harboring GNAS R201C and R201H mutations: a case report
Author(s) -
You Li,
Chao Zhou,
Zhonghai Chen,
Xinqing Zhao,
Yuhan Sun,
Jieyi Li,
Zhongmiao Gong,
Daoyuan Zhang,
Hai Huang
Publication year - 2022
Publication title -
anti-cancer drugs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.651
H-Index - 93
eISSN - 1473-5741
pISSN - 0959-4973
DOI - 10.1097/cad.0000000000001342
Subject(s) - osimertinib , gnas complex locus , trametinib , t790m , medicine , lung cancer , crizotinib , oncology , cancer research , adenocarcinoma , epidermal growth factor receptor , cancer , gefitinib , kinase , biology , mapk/erk pathway , erlotinib , gene , genetics , malignant pleural effusion